The Latest Breaking News from Novo

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Amgen stock surged Tuesday on a reportedly bullish call for its experimental obesity treatment — a potential rival to Novo and Lilly.

LOS ANGELES — In September, Steve Lacy sauntered into the glassy upstairs lounge at the Novo in downtown L.A. bearing some remarkable news. The 24-year-old, Compton-raised singer-songwriter, dressed in a flowy trench coat, shoulder-length braids and imposing full-face sunglasses, had just learned that "Bad Habit," his bummed-out yet deliriously horny…

Novo Nordisk said Thursday it will spend $1.1 billion to acquire Forma in a deal that sent biotech stock Forma flying.

A group of pharmaceutical stocks are climbing as they pivot their diabetes drugs to help treat obesity. A potential multibillion-dollar market beckons them.

With a new album to play live, English rock band Royal Blood was ready to go when it launched its tour in the United Kingdom earlier this year.

Novo restaurant in Morpeth has become a big favourite with celebrities including Kieran and his Newcastle United team mates

Novo Nordisk A/S (NYSE: NVO) has more than doubled its target for sales of obesity drugs by 2025 after overwhelming demand for its new Wegovy drug.